Nonoxynol-9 Labeling Changes Under Discussion At FDA
This article was originally published in The Tan Sheet
Executive Summary
Modifications of nonoxynol-9 (N-9) labeling are being considered by FDA, but the spermicide's OTC status appears to be safe for the time being
You may also be interested in...
Vaginal Contraceptive N-9 Label Warnings Urged “As Soon As Possible” – FDA
Manufacturers of vaginal contraceptives containing nonoxynol-9 should voluntarily implement proposed label warnings about increased vaginal irritation and HIV infection risk "as soon as possible," FDA advises in a 1Jan. 16 proposed rule
Cascara Sagrada, Aloe Laxatives, O-9 Contraceptive Are Category II – FDA
Reformulation of all cascara sagrada- and aloe-containing laxatives with approved active ingredients could cost industry up to $17.8 mil., including an estimated relabeling cost of $612,000, FDA states
N-9 Lubricated Condom Buys, Spermicide Use Discouraged In CDC Guidelines
The Centers for Disease Control & Prevention is advising against future purchases of condoms lubricated with nonoxynol-9 (N-9) spermicide